耐受性前列腺癌-话题@MedSci

#耐受性前列腺癌#

3篇内容 | 592人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2042479, encodeId=ced720424e98d, content=<a href='/topic/show?id=86168035236' target=_blank style='color:#2F92EE;'>#耐受性前列腺癌#</a>, objectTitle=NEJM：恩杂鲁胺用于治疗去势耐受性前列腺癌, objectType=article, longId=195323, objectId=989d195323d7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=989d195323d7, replyNumber=0, likeNumber=27, createdTime=2020-08-30, rootId=0, userName=flyingeagle77, userId=9fe6351, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=989d195323d7, moduleTitle=NEJM：恩杂鲁胺用于治疗去势耐受性前列腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=989d195323d7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2042478, encodeId=292320424e871, content=<a href='/topic/show?id=86168035236' target=_blank style='color:#2F92EE;'>#耐受性前列腺癌#</a>, objectTitle=Lancet oncol：醋酸阿比特龙联合镭-223不能延长去势耐受性前列腺癌骨转移患者的无症状骨骼事件存活期, objectType=article, longId=159655, objectId=7e6a15965554, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e6a15965554, replyNumber=0, likeNumber=47, createdTime=2019-12-26, rootId=0, userName=flyingeagle77, userId=9fe6351, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e6a15965554, moduleTitle=Lancet oncol：醋酸阿比特龙联合镭-223不能延长去势耐受性前列腺癌骨转移患者的无症状骨骼事件存活期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e6a15965554)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2042477, encodeId=967820424e786, content=<a href='/topic/show?id=86168035236' target=_blank style='color:#2F92EE;'>#耐受性前列腺癌#</a>, objectTitle=Cancer：去势耐受性前列腺癌患者肝和/或肺转移后接受enzalutamid治疗效果更好, objectType=article, longId=78936, objectId=4acee8936ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4acee8936ab, replyNumber=0, likeNumber=37, createdTime=2017-08-12, rootId=0, userName=flyingeagle77, userId=9fe6351, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4acee8936ab, moduleTitle=Cancer：去势耐受性前列腺癌患者肝和/或肺转移后接受enzalutamid治疗效果更好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4acee8936ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

耐受性前列腺癌

2020-05-29

flyingeagle77 (审核中...)

前往app查看评论内容

#耐受性前列腺癌#

NEJM：恩杂鲁胺用于治疗去势耐受性前列腺癌

2020-08-30

flyingeagle77 (审核中...)

前往app查看评论内容

#耐受性前列腺癌#

Lancet oncol：醋酸阿比特龙联合镭-223不能延长去势耐受性前列腺癌骨转移患者的无症状骨骼事件存活期

2019-12-26

flyingeagle77 (审核中...)

前往app查看评论内容

#耐受性前列腺癌#

Cancer：去势耐受性前列腺癌患者肝和/或肺转移后接受enzalutamid治疗效果更好

2017-08-12

科室
- - 订阅+
  - 更多科室
工具
服务